CLINICAL_TRIALS
trial_result
· 2016-06-02
Clinical Trial Update: A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors [Phase 1]
Summary
A Phase 1 cardiac safety study of evofosfamide (TH-302) in patients with advanced solid tumors; the current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Threshold Pharmaceuticals | Conditions: Solid Tumors | Phase 1 | Status: UNKNOWN